Nasdaq

Abbott Completes In-human Left Bundle Branch Area Pacing Procedures Using AVEIR CSP Pacemaker

(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
Seeking Alpha

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

Abbott (ABT)'s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...
TCTMD

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

Better devices and changes in implant depth have likely led to fewer LBBBs over time, but the issue needs continued attention ...
Morningstar

Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology

Abbott's UltiPace™ Pacing Lead is the first FDA-approved stylet-driven lead indicated for left bundle branch area placement. Recently, the U.S. Food and Drug Administration (FDA) granted Breakthrough ...
Healio

FDA approves expanded indication for pacing leads to include conduction pacing of LBB area

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...